Does Mounjaro fatigue go away — and how long does it take?

Fatigue is a recognised side effect of tirzepatide, listed in the Mounjaro SmPC and the NHS medicines information for the drug.
It is most common when treatment starts or the dose steps up, and usually settles within days to two weeks as the body adjusts.
Persistent or severe tiredness that does not ease should be discussed with your prescriber, it can occasionally signal dehydration or another issue needing attention.
All suspected side effects can be reported directly to the MHRA via the Yellow Card scheme at yellowcard.mhra.gov.uk.

For most people, fatigue on Mounjaro does go away. Clinical trial data and NHS guidance both describe tiredness as a common but typically short-lived side effect, most noticeable in the first few weeks of starting treatment or after a dose increase, then settling as the body adjusts. It is a prescription-only medicine, and a prescriber will weigh up your full picture before it is dispensed. If you are finding the fatigue difficult to manage, that conversation matters — read on for what the evidence actually says about Mounjaro fatigue and when to expect it to ease.

Starting from £29.99/mo

Free 2-minute consultation · Reviewed same day

Start journey
The nume Promise

Order by 12pm.

At your door the next working day.
Free, tracked, plain packaging.

Guaranteed on approved orders

Where are you starting from?

BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.

Check your BMI.

Ten seconds. Private — nothing is stored or shared.

80 kg
170 cm

Your result updates live in the card alongside.

Your result

Your BMI is

which is in the healthy weight range

Start journey

BMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.

Treatment options

Weight loss treatments

The problem

Most weight loss services treat you like a transaction, a checkout, a courier, and you're on your own.

Algorithm approvalsNo real clinicianGeneric dosingHidden feesSlow deliverySilence after checkout

The nume way

We built the opposite: one clinician who knows you, guaranteed care at every step.

24 hrs

clinician review. Free next working day delivery.

How it works

From consultation to your door, properly.

Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.

Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.

Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.

What the trial data and NHS guidance say about tirzepatide fatigue, and how to get through it

What the SURMOUNT trial data recorded about fatigue

In the SURMOUNT-1 phase-3 trial, fatigue was reported as an adverse event across all active tirzepatide arms. The published data, which informed NICE's appraisal of tirzepatide (TA1026), show it was more frequent at the point of dose escalation and in the early weeks of treatment, not as a steady feature throughout the 72-week study period. That pattern is meaningful: it suggests the tiredness is largely a response to the body adapting to a new dose rather than an ongoing effect of the medicine itself. The SURMOUNT programme enrolled thousands of adults and the pattern held consistently across dose groups, the fatigue signal was real, but it was also time-limited for the vast majority of participants.

The NHS medicines page for tirzepatide lists tiredness among the common side effects and notes that these effects typically settle as treatment continues. NHS guidance does not describe fatigue as a reason to stop treatment in otherwise well-tolerating patients, which gives a reasonable steer on how clinicians view its severity in context.

Does tirzepatide fatigue go away entirely? For most people, yes. A small number find some degree of ongoing tiredness, often linked to reduced calorie intake rather than the medicine directly. Understanding the cause shapes how you manage it, which is covered below.

Why the tiredness happens, and what tends to make it worse

Mounjaro slows gastric emptying and reduces appetite. Both effects are central to how it works, and both can contribute to tiredness if food and fluid intake drop sharply in the early weeks. Low calorie intake reduces the energy available to cells; mild dehydration from gastrointestinal side effects like nausea adds to that. If you are also noticing loose stools, it is worth reading about whether Mounjaro diarrhea goes away, as that particular side effect can compound dehydration and leave you feeling more drained. Neither is dangerous at a low level, but together they can leave you feeling genuinely flat.

There is also a dose-timing element. Many people notice fatigue most acutely in the 24–48 hours after their weekly injection, particularly when they are on a lower dose during titration. Keeping a note of when tiredness peaks relative to injection day can help you and your prescriber spot the pattern, and plan accordingly. Some people find it useful to take their injection on a Friday evening so that any tiredness over the following day or two sits across a weekend rather than a working morning. It is a small practical adjustment, but it matters. Your pen lives in the fridge door; the day you take it out is something you can choose.

For a more detailed look at the causes and the typical timeline, the page on why Mounjaro causes fatigue covers the mechanism in full. And if you are wondering how this compares with other Mounjaro side effects that resolve over time, which Mounjaro side effects go away gives a broader picture.

How long does the fatigue typically last?

The honest answer is that it varies. Most people who experience fatigue at the start of treatment or after a dose increase find it settles within one to two weeks. That timeline is consistent with the gastro-intestinal side-effect profile described in the Mounjaro SmPC, where common GI effects are described as transient and most frequent early in treatment or at dose escalation.

If fatigue is still pronounced after two weeks on a stable dose, a few things are worth considering. Protein and fluid intake are the first places to look: reduced appetite can lead people to eat too little protein, which affects energy and muscle function over weeks rather than days. Hydration is easier to underestimate on GLP-1 treatment than people expect. A modest reduction in physical activity, which some people adopt instinctively when tired, can paradoxically worsen fatigue over time.

Fatigue that is getting worse rather than better, or that is accompanied by other symptoms, warrants a prompt conversation with your prescriber. The page on how long Mounjaro fatigue lasts goes into the typical timelines by dose stage in more detail. More broadly, the full overview of Mounjaro side effects puts fatigue in the context of the treatment's complete safety profile.

When to seek medical help, and what counts as a red flag

Mild tiredness that eases over days is expected and manageable. Some symptoms alongside fatigue are not, and knowing the difference matters.

Seek urgent medical attention if fatigue is accompanied by severe and persistent stomach pain that radiates to the back, with or without vomiting. This combination is a potential sign of acute pancreatitis, which the MHRA highlighted in a Drug Safety Update for GLP-1 medicines in January 2026. It is an infrequent but serious side effect, and speed matters if it occurs.

Other symptoms that warrant prompt medical contact alongside tiredness include: signs of dehydration (very dark urine, dizziness on standing, inability to keep fluids down), yellowing of the skin or whites of the eyes, or any signs of a serious allergic reaction such as swelling of the face or throat, or difficulty breathing. These are listed in the Mounjaro patient information leaflet and on the MHRA Yellow Card scheme, where you can report any suspected side effect (including fatigue that concerns you) directly to the regulator.

If you have questions about fatigue before starting treatment, or you are already on Mounjaro and your energy levels are not improving as expected, our prescribers at nume discuss side effects as part of every consultation and review. Check your eligibility to speak with a clinician who can assess your individual situation.

Looking to start your weight loss journey?
Take a quick eligibility quiz to explore your options and see how we can support you.
Start free consultation

The people

Meet the team.

Mahommed Zunaid Ayub Patel

Superintendent Pharmacist (GPhC No. 2217101)

Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.

Mostafa Damghani

Clinical Lead (GPhC No. 2231744)

Sets our clinical standards and checks everything we publish against current MHRA guidance.

Shelan Salih

Independent Prescriber (GPhC No. 2084501)

Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.

Rehenaaz Uddin

Independent Prescriber (GPhC No. 2083426)

Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.

Frequently asked questions